Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAn NIH-wide notice about replacing “Artificial Intelligence” with “Super Intelligence” was added, and the site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.4%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision indicator changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check51 days agoChange DetectedA new revision entry v3.7.0 was added to the study's record history, and the previous revision v3.6.6 was removed, updating the version trail to reflect the latest state.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision label on the page history updates to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check86 days agoChange DetectedThe record history shows a new platform release, v3.6.5, added and the previous release, v3.6.4, removed, indicating a page-wide software update.SummaryDifference0.0%

Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.